MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
$774,518
Unit: Dollar
Positive Cash Flow Breakdown
    • Prepaid expenses and other asset...
    • Subscription liability
    • Accounts payable and accrued exp...
    • Change in fair value of derivati...
Negative Cash Flow Breakdown
    • Net loss
    • Payments on notes payable

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net increase (decrease) in cash
NaN -493,016 NaN NaN
Investment in related party receivable
NaN 0 0 NaN
Effect of exchange rates on cash
NaN 0 0 0
Depreciation
NaN 0 0 0
Amortization of debt discount
NaN 0 0 NaN
Inducement expense
NaN 0 0 0
Write-off related party note receivable
NaN 0 NaN NaN
Change in fair value of contingent consideration
NaN 0 0 0
Right of use asset
NaN 0 0 0
Operating lease liability
NaN 0 0 0
Stock-based compensation
NaN 0 0 20,783
Asset impairment loss
NaN 0 0 402,746
Net loss
-810,791 -656,885 -472,506 -7,148,459
Change in fair value of derivative financial instrumentswarrants
10,153 34,620 -47,275 4,102,408
Accounts payable and accrued expenses
240,255 112,217 -88,093 -22,693
Prepaid expenses and other assets
-1,138,967 -177,273 -161,911 -152,433
Net cash provided by (used in) operating activities
578,584 -332,775 -445,963 -2,492,782
Investment in related party receivable
NaN 0 NaN NaN
Investment in license agreement
NaN 0 0 132,117
Investment in license agreement
NaN 0 NaN NaN
Net cash used in investing activities
NaN 0 0 -132,117
Net cash used in investing activities
NaN 0 NaN NaN
Subscription liability
250,000 0 0 NaN
Proceeds from the issuance of common stock and warrants, net
NaN 0 0 9,000,000
Equity issuance costs
NaN 0 0 802,597
Payments on notes payable
54,066 160,241 157,354 3,054,517
Net cash provided by financing activities
195,934 -160,241 -157,354 5,142,886
Net increase in cash
774,518 -493,016 -603,317 2,517,987
Cash at beginning of period
1,828,062 2,321,078 406,408 NaN
Cash at end of period
2,602,580 1,828,062 2,321,078 NaN
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Prepaid expenses andother assets-$1,138,967 Subscription liability$250,000 Accounts payable andaccrued expenses$240,255 Change in fair value ofderivative financial...$10,153 Net cash provided by(used in) operating...$578,584 Net cash provided byfinancing activities$195,934 Canceled cashflow$810,791 Canceled cashflow$54,066 Net increase in cash$774,518 Net loss-$810,791 Payments on notes payable$54,066

Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals, Inc. (HEPA)